46 related articles for article (PubMed ID: 11832139)
1. [MMF and CyA in the prevention of early acute rejection after renal transplantation].
He B; Han X; Liu J; Han Z; Guan D; Gao J
Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):683-5. PubMed ID: 11832139
[TBL] [Abstract][Full Text] [Related]
2. A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation.
Cherikh WS; Myron Kauffman H; Maghirang J; Bleyer AJ; Johnson CP
Transplantation; 2003 Aug; 76(3):463-70. PubMed ID: 12923430
[TBL] [Abstract][Full Text] [Related]
3. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
4. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin in renal transplantation: a 9 year experience.
Yuan ZF; Bailey RR; Gardner J
N Z Med J; 1995 Feb; 108(993):29-32. PubMed ID: 7891931
[TBL] [Abstract][Full Text] [Related]
6. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
7. Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?
Mahalati K; Lawen J; Kiberd B; Belitsky P
J Urol; 2000 Jan; 163(1):37-41. PubMed ID: 10604309
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic behavior of cyclosporine A in liver dysfunction.
Kihira K; Kadoyama M; Miyake K; Kitaura T; Kimura Y; Yoshida M; Fukuchi H
Hiroshima J Med Sci; 1994 Dec; 43(4):175-8. PubMed ID: 7883584
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting therapeutic effect of anti-CD3 and CD4 monoclonal antibody in acute renal allograft rejection.
Wang XH; Xie T
Transplant Proc; 1996 Jun; 28(3):1306-8. PubMed ID: 8658671
[TBL] [Abstract][Full Text] [Related]
10. Preliminary experience with mycophenolate mofetil for preservation of renal function in cardiac transplant patients with documented cyclosporine nephrotoxicity.
Al-Aly Z; Sachdeva A; Philoctete Ashley JM; Bastani B
Nephrology (Carlton); 2006 Apr; 11(2):151-5. PubMed ID: 16669979
[TBL] [Abstract][Full Text] [Related]
11. [Half-dose Zenapax for acute rejection prevention after renal transplantation].
Zhu YS; Xu AP; He HX; Fan LP; Nie HB; Nv J; Hu WN; Li QR; Deng ZX
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1818-20. PubMed ID: 17259129
[TBL] [Abstract][Full Text] [Related]
12. Causes of long-term graft failure in renal transplantation.
Tanabe K; Takahashi K; Toma H
World J Urol; 1996; 14(4):230-5. PubMed ID: 8873436
[TBL] [Abstract][Full Text] [Related]
13. [Study of 54 renal allograft recipients in the cyclosporin A era. What influences acute rejection episode and long-term graft survival?].
Tanda K; Takeuchi I; Chikaraishi T; Togashi M; Koyanagi T; Kanagawa K; Hirano T; Seki T; Tsubo S
Nihon Hinyokika Gakkai Zasshi; 1992 Dec; 83(12):1970-7. PubMed ID: 1474704
[TBL] [Abstract][Full Text] [Related]
14. The potential of steroids and xenobiotic receptor polymorphisms in forecasting cyclosporine pharmacokinetic variability in young kidney transplant recipients.
Ferraresso M; Turolo S; Belinghieri M; Tirelli AS; Grillo P; Groppali E; Edefonti A; Ghio L
Pediatr Transplant; 2012 Sep; 16(6):658-63. PubMed ID: 22765024
[TBL] [Abstract][Full Text] [Related]
15. Early acute rejection and kidney allograft outcome in children.
Chavers B
Pediatr Transplant; 1998 Nov; 2(4):254-6. PubMed ID: 10084725
[No Abstract] [Full Text] [Related]
16. Malononitrilamides synergistically prevent acute and treat ongoing skin allograft rejection with cyclosporine.
Schorlemmer HU; Ruuth E; Kurrle R
Transpl Int; 1998; 11 Suppl 1():S340-4. PubMed ID: 9665012
[TBL] [Abstract][Full Text] [Related]
17. [Current status of kidney transplantation. Results in Austria].
Zazgornik J
Wien Med Wochenschr; 1987 Aug; 137(14-15):336-40. PubMed ID: 3314171
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of renal allografts by Doppler ultrasound.
Ubhi CS; Irving HC; Norwood HM; Guillou PJ; Giles GR
Ann R Coll Surg Engl; 1987 Sep; 69(5):229-32. PubMed ID: 3314635
[TBL] [Abstract][Full Text] [Related]
19. Fractional excretion of sodium represents an index of cyclosporine nephrotoxicity in the early post-transplant period.
Morales JM; Andres A; Prieto C; Ruilope LM; Alcazar JM; Oliet A; Praga M; Rodicio JL
Transplant Proc; 1987 Oct; 19(5):4005-7. PubMed ID: 3313985
[TBL] [Abstract][Full Text] [Related]
20. Effect of active infection on cytochrome P450-mediated metabolism of cyclosporine in renal transplant patients.
Hegazy SK; Adam AG; Hamdy NA; Khalafallah NM
Transpl Infect Dis; 2015 Jun; 17(3):350-60. PubMed ID: 25702620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
